Discovery data demonstrates strong sensitivity and specificity in detecting active disease across six different types of substance use disorder FRAMINGHAM, MA / ACCESS Newswire / April 8, 2025 / ...
Groundbreaking urine test provides deeper insight into hormone metabolism, endocrine disruptors, oxidative stress, and bone health to support data-backed clinical decisions SANTA CLARA, CALIFORNIA / ...
FAYETTEVILLE, ARKANSAS / ACCESS Newswire / April 8, 2025 / While, for most children, life is an adventure and a never-ending road of discovery, many others are not that lucky, facing a journey of pain ...
DUBAI, UAE / ACCESS Newswire / April 8, 2025 / ATS Medical, a division of the ATS Group and a trusted provider of critical medical equipment and logistics, will attend three of the medical and ...
Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech ...
The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 ...
The global CD Antigen Cancer Therapy Market is valued at USD 27.5 Billion in 2024 and is projected to reach a value of USD 54 ...
The Pancreatic Cancer Therapy Market is one of the rapidly expanding sectors within the global oncology industry. Pancreatic cancer is known for its aggressive nature, with a low survival rate, making ...
Brainomix, a global leader in AI-powered stroke imaging, has announced the FDA clearance of a novel and patented feature that enables physicians to assess ischemic core volume from universally ...
Pharmacies across the UK dispense thousands of prescriptions daily, aiming to ensure that patients receive the right medications combined with the correct instructions for their use. Despite the best ...
LUND, SWEDEN / ACCESS Newswire / April 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and ...
CRISPR MarketThe CRISPR Market had an estimated market share worth USD 3.4 billion in 2023, and it is predicted to reach a global market valuation of USD 17.8 billion by 2034, growing at a CAGR of 16.